A machine learning approach to risk-stratification of gastric cancer based on tumour-infiltrating immune cell profiles
Background Gastric cancer (GC) is a highly heterogeneous disease, and the response of patients to clinical treatment varies substantially. There is no satisfactory strategy for predicting curative effects to date. We aimed to explore a new method for predicting the clinical efficacy of GC treatment...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2489007 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850187441784225792 |
|---|---|
| author | Yanping Hu Bo Wang Chao Shi Pengfei Ren Chengjuan Zhang Zhizhong Wang Jiuzhou Zhao Jiawen Zheng Tingjie Wang Bing Wei He Zhang Rentao Yu Yihang Shen Jie Ma Yongjun Guo |
| author_facet | Yanping Hu Bo Wang Chao Shi Pengfei Ren Chengjuan Zhang Zhizhong Wang Jiuzhou Zhao Jiawen Zheng Tingjie Wang Bing Wei He Zhang Rentao Yu Yihang Shen Jie Ma Yongjun Guo |
| author_sort | Yanping Hu |
| collection | DOAJ |
| description | Background Gastric cancer (GC) is a highly heterogeneous disease, and the response of patients to clinical treatment varies substantially. There is no satisfactory strategy for predicting curative effects to date. We aimed to explore a new method for predicting the clinical efficacy of GC treatment based on immune variables detected via flow cytometry.Methods We collected 394 tumour tissues from GC patients for flow cytometry analysis and gating analysis of tumour-infiltrating immune cells (TIICs). Unsupervised consensus clusters were generated from the cohort to classify patients into different phenogroups, and their clinical characteristics were examined. The derived model was evaluated via principal component analysis and t-distributed stochastic neighbourhood embedding analysis. Kaplan–Meier’s curves were used to determine the prognosis during a 920-day-long median follow-up period (interquartile range: 834–1071 days). Adjusted multivariate Cox regression analysis was used to evaluate the association of clusters with disease-free survival (DFS) and recurrence.Results All patients were classified based on their TIIC profiles into the C1 (characterized by low CD45 negative cell, high lymphocyte, high neutrophil and low CD3 + T cell levels), C2 (characterized by high CD8 + CD279+ cell and low CD4+ Th and CD8+ Tc cell numbers) and C3 (characterized by high CD4 + CD25+ and Treg cell levels) phenogroups. Patients from the three clusters had varied pathologies, MMR statuses and TIIC distribution patterns (p < .05). Kaplan–Meier’s analysis showed that the prognosis of C3 was inferior compared to C1 and C2 (p = .0025). Adjusted Cox proportional hazard models helped us identify that C1 and C2 exhibited a favourable factor of recurrence after surgery, compared to C3. Kaplan–Meier’s analysis showed that C1 and C2 were associated with a better DFS than C3 in some GC patient subgroups.Conclusions The machine learning model developed was found to be effective model at predicting the prognosis of patients with GC and their TIIC profiles for risk stratification in clinical settings. |
| format | Article |
| id | doaj-art-40fa3eec9b6c4fc08b425a40d49fc157 |
| institution | OA Journals |
| issn | 0785-3890 1365-2060 |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Annals of Medicine |
| spelling | doaj-art-40fa3eec9b6c4fc08b425a40d49fc1572025-08-20T02:16:06ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602025-12-0157110.1080/07853890.2025.2489007A machine learning approach to risk-stratification of gastric cancer based on tumour-infiltrating immune cell profilesYanping Hu0Bo Wang1Chao Shi2Pengfei Ren3Chengjuan Zhang4Zhizhong Wang5Jiuzhou Zhao6Jiawen Zheng7Tingjie Wang8Bing Wei9He Zhang10Rentao Yu11Yihang Shen12Jie Ma13Yongjun Guo14Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaCenter of Repository, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaCentral Laboratory, Suzhou Ninth People’s Hospital, Suzhou, ChinaDepartment of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, ChinaBackground Gastric cancer (GC) is a highly heterogeneous disease, and the response of patients to clinical treatment varies substantially. There is no satisfactory strategy for predicting curative effects to date. We aimed to explore a new method for predicting the clinical efficacy of GC treatment based on immune variables detected via flow cytometry.Methods We collected 394 tumour tissues from GC patients for flow cytometry analysis and gating analysis of tumour-infiltrating immune cells (TIICs). Unsupervised consensus clusters were generated from the cohort to classify patients into different phenogroups, and their clinical characteristics were examined. The derived model was evaluated via principal component analysis and t-distributed stochastic neighbourhood embedding analysis. Kaplan–Meier’s curves were used to determine the prognosis during a 920-day-long median follow-up period (interquartile range: 834–1071 days). Adjusted multivariate Cox regression analysis was used to evaluate the association of clusters with disease-free survival (DFS) and recurrence.Results All patients were classified based on their TIIC profiles into the C1 (characterized by low CD45 negative cell, high lymphocyte, high neutrophil and low CD3 + T cell levels), C2 (characterized by high CD8 + CD279+ cell and low CD4+ Th and CD8+ Tc cell numbers) and C3 (characterized by high CD4 + CD25+ and Treg cell levels) phenogroups. Patients from the three clusters had varied pathologies, MMR statuses and TIIC distribution patterns (p < .05). Kaplan–Meier’s analysis showed that the prognosis of C3 was inferior compared to C1 and C2 (p = .0025). Adjusted Cox proportional hazard models helped us identify that C1 and C2 exhibited a favourable factor of recurrence after surgery, compared to C3. Kaplan–Meier’s analysis showed that C1 and C2 were associated with a better DFS than C3 in some GC patient subgroups.Conclusions The machine learning model developed was found to be effective model at predicting the prognosis of patients with GC and their TIIC profiles for risk stratification in clinical settings.https://www.tandfonline.com/doi/10.1080/07853890.2025.2489007Gastric cancertumour-infiltrating immune cellsflow cytometryrisk stratificationdisease-free survival |
| spellingShingle | Yanping Hu Bo Wang Chao Shi Pengfei Ren Chengjuan Zhang Zhizhong Wang Jiuzhou Zhao Jiawen Zheng Tingjie Wang Bing Wei He Zhang Rentao Yu Yihang Shen Jie Ma Yongjun Guo A machine learning approach to risk-stratification of gastric cancer based on tumour-infiltrating immune cell profiles Annals of Medicine Gastric cancer tumour-infiltrating immune cells flow cytometry risk stratification disease-free survival |
| title | A machine learning approach to risk-stratification of gastric cancer based on tumour-infiltrating immune cell profiles |
| title_full | A machine learning approach to risk-stratification of gastric cancer based on tumour-infiltrating immune cell profiles |
| title_fullStr | A machine learning approach to risk-stratification of gastric cancer based on tumour-infiltrating immune cell profiles |
| title_full_unstemmed | A machine learning approach to risk-stratification of gastric cancer based on tumour-infiltrating immune cell profiles |
| title_short | A machine learning approach to risk-stratification of gastric cancer based on tumour-infiltrating immune cell profiles |
| title_sort | machine learning approach to risk stratification of gastric cancer based on tumour infiltrating immune cell profiles |
| topic | Gastric cancer tumour-infiltrating immune cells flow cytometry risk stratification disease-free survival |
| url | https://www.tandfonline.com/doi/10.1080/07853890.2025.2489007 |
| work_keys_str_mv | AT yanpinghu amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT bowang amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT chaoshi amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT pengfeiren amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT chengjuanzhang amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT zhizhongwang amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT jiuzhouzhao amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT jiawenzheng amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT tingjiewang amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT bingwei amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT hezhang amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT rentaoyu amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT yihangshen amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT jiema amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT yongjunguo amachinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT yanpinghu machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT bowang machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT chaoshi machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT pengfeiren machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT chengjuanzhang machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT zhizhongwang machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT jiuzhouzhao machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT jiawenzheng machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT tingjiewang machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT bingwei machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT hezhang machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT rentaoyu machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT yihangshen machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT jiema machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles AT yongjunguo machinelearningapproachtoriskstratificationofgastriccancerbasedontumourinfiltratingimmunecellprofiles |